<DOC>
	<DOCNO>NCT02857257</DOCNO>
	<brief_summary>Patients irritable bowel syndrome ( IBS ) treat microbiota human intestinal anaerobic sample culture decade . Patients recruit consecutively symptoms IBS serve control . After observation time 4 week , patient recruit 1-week run-in give cultured fecal microbiota duodenal route via gastroscopy . Two treatment give within 1-week interval . Assessment symptom make 4 week last treatment ( 6 week ) . Additionally , fecal sample collect bacterial 16S ribosomal ribonucleic acid ( rRNA ) analysis bacterial functional parameter ( microflora-associated characteristic ) .</brief_summary>
	<brief_title>Transplantation Anaerobic Cultured Human Intestinal Microbiota Irritable Bowel Syndrome</brief_title>
	<detailed_description>Diarrhea-dominated irritable bowel syndrome ( IBS-D ) study subject treatment anaerobic human intestinal microbiota culture 15 year quality control specify content bacterial specie regularly year . Inclusion criterion : Diarrheal disease since least 4 week , 18-80 year age , previously unsuccessful treatment symptomatic relief antidiarrheal resin , sign informed consent . Primary outcome irritable bowel syndrome-symptom severity scale ( IBS-SSS ) . Secondary outcome Bristol stool scale ( BSS ) . Secondary outcome : Changes fecal microflora distribution multiplicity show 16S ribosomal ribonucleic acid ( rRNA ) analysis feces . Once eligible study , patient monitor run-in period one week IBS-SSS BSS plus fecal sample analysis bacterial specie use bacterial specific 16S rRNA differentiation . Then , anaerobic culture human intestinal microflora ( ACHIM ) give twice interval 1 week . Thereafter , patient monitor 4 week regard IBS-SSS BSS . Another feces sample also collect bacterial 16S rRNA analysis evaluate microbiota diversity . The study evaluate use eligible subject control mean Wilcoxon 's matched-pairs test , alternatively t-test match pair . Power analysis show 40 subject need study order achieve power 80 % .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>IBS accord Rome III criterion Pregnancy Antibiotic probiotic within 8 week inclusion Unable give inform consent Immunodeficiency ( drug och diseaserelated )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>IBS</keyword>
	<keyword>Microbiota</keyword>
</DOC>